首页> 中文期刊>中国医药指南 >中心静脉导管引流恶性胸腔积液的临床护理分析

中心静脉导管引流恶性胸腔积液的临床护理分析

     

摘要

Objective The forty-six cases of patients with malignant pleural effusion indwelling central venous catheter, and clinical care points to explore the advantages of central venous catheter drainage of the chest.Methods A retrospective analysis was collected in our department from January 2013 to January 2014 in 72 cases of breast cancer occur in patients with lung cancer and malignant pleural effusion were randomly divided into a treatment group 46 cases and a control group of 26 cases. The control group gives closed thoracic drainage. The treatment group received central venous catheter drainage.Results The patients were successfully completed treatment, serious complications have occurred in the treatment group pleural effusion total effective rate 80.00%remission, KPS score higher and quality of life of patient’s progression-free survival (PFS) and overall survival (OS) significantly prolonged.Conclusion Patients with malignant pleural effusion indwelling central venous catheter with a minimally invasive advantages, through the reasonable clinical nursing science which can significantly reduce the chances of infection and the clinical care is worth attention.%目的:通过46例恶性胸腔积液患者留置中心静脉导管引流,探讨中心静脉导管行胸腔引流的优势及临床护理要点。方法采用回顾性分析的方法,收集我科2013年1月至2014年1月的72例肺癌及乳腺癌患者出现恶性胸水的患者,随机分为治疗组46例和对照组26例,对照组给予胸腔闭式引流术;治疗组给予中心静脉导管引流。结果治疗组患者均顺利完成治疗,未发生严重得并发症,治疗组胸水缓解总有效率达80.00%,生活质量KPS评分较高,患者无进展生存期(PFS)和总生存期(OS)明显延长。结论恶性胸腔积液患者留置中心静脉导管引流具有微创的优势,通过临床合理、科学的护理,可明显降低感染概率,值得临床护理的重视。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号